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1. Introduction 
Obesity is the noticeably fat mass, and an excessive nutrient intake is a cause of that. When 
the energy in body exceeds healthy limit, the much energy is stored as fat or in fatty tissue. 
Obesity was accelerated by eating fatty foods, insufficient exercise, and accumulation of 
stress.  
Obesity has come to be recognized as a critical global health issue. Rates of obesity in North 
America and in most European countries have more than doubled in the last 20 years and 
over half the adult population are now either overweight or obese (1). According to the 
report which was released by Korea National Health Insurance Corporation (NHIC) in 2004, 
the obesity rate for subjects of the survey in 2003 was 56%, and increased in all age groups 
from 10s to 60s. In addition, the study by Oh et al. in 2005 reported that obesity was strongly 
associated with risk of some cancers, such as skin, liver, large intestine, thyroid gland, 
biliary tract, and uterus. It is well known that obesity is one of the causes that generate heart 
problems, diabetes, and other disorders (2).  
Conjugated linoleic acid (CLA) is one of trans fatty acids and found mainly in the meat and 
dairy products of ruminants (3). CLA has received attention for its antioxidant and anti-
cancer properties (4). Studies of CLA show that CLA supplementation tends to reduce body 
fat, improve serum lipid profiles, and decrease whole-body glucose uptake. However, the 
results of some studies on rats suggest that CLA supplement was not effective in reducing 
the fat accumulation (5). Though studies done on CLA have increased, they do not all show 
uniform results, showing it is necessary to summarize and analyze them. 
Meta-analysis is a tool for summarizing the results of studies with related research 
hypotheses. It has three steps; deciding the association measure for detecting difference 
between groups, summarizing the association measure in assumed model, and identifying 
publication bias. The association measures in meta-analysis are the measure of related 
effects from the primary research such as the standardized mean difference, the mean 
difference, the risk difference, and an odds ratio. The decided measure is combined using 
only within variation of studies on the assumption that the results are homogeneity and 
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uniformly distributed, and then it is tested on whether the homogeneity assumption is 
plausible. If the results are heterogeneity, the measure is recombined using within variation 
with the estimated the between variations of the studies. The former model is called the 
fixed effect model and the latter is the random effect model. Because significant results are 
more likely to be submitted or accepted than insignificant ones and the combined estimates 
are calculated by only published researches, the bias easily occurs in a small number of 
studies and is called the publication bias. If the publication bias is doubtable, the combined 
estimate is adjusted or the additional studies are required (6, 7).  
The purpose of this study was to summarize the studies about effect of CLA on factors 
related to the anti-obesity in experimental rats by meta-analysis. 
2. Method 
2.1 Preparation of dataset for meta-analysis 
The studies used in this meta-analysis were searched on the ScienceDirect in English, the 
DBpia database, and the KISS (Koreanstudies Information Service System) in Korean. The 
search keywords used were CLA, weight, health, or fat and the research was limited to the 
experimental rat studies. About 50 studies were collected and 12 studies were finally 
selected after omitting some studies with insufficient information, such as no sample 
variance or no sample size (5, 8-18).  
The factors used to investigate the effect of CLA were collected from target studies, if it was 
studied in at least 2 studies. The selected factors were body fat (%), epididymal fat (g/100g), 
fat cell size (μm), final body weight (g), food intake (g/d), leptin (pg/ml), liver-TC (mg/g), 
liver-TG (mg/g), plasma-TC (mg/dl), plasma-TG (mg/dl), and weight gain (g/d). The unit 
of each factor was uniformly changed. 
 In each study, there were two groups. One group of rats was treated with fat source such as 
beef tallow, coconut oil, corn oil, fish oil, safflower oil or soybean oil (FR), and the other 
group of rats was treated with fat source supplemented with CLA (FRC). Because the size of 
studies after grouping by treated fat source was not enough large, the each fat source has 
similar effect on obesity. 
2.2 Measure and models for combining 
Since the mean difference between FR and FRC was used for test on anti-obesity effect of 
CLA, the association measure was decided as the mean difference (MD) of each factor; mean 
of FRC minus mean of FR. The combined MD of each factor was calculated by the inverse 
variance method and the mean weighted by inverse variance in the primary studies. If the 
homogeneity was accepted by Cochran’s Q test, it is assumed that the effect measured in the 
study population has a single value. The association measure is estimated by using a 
variation within the studies in the fixed effect model. To reduce the bias caused by 
heterogeneity, meta-regression models are used to analyze association between treatment 
effects and study characteristics. The period and amount of CLA supplementation were 
considered as covariates, and the estimated coefficients of covariates were investigated for 
possible sources of heterogeneity. If the homogeneity was rejected, the combined MDs of 
studies were calculated in random effect model in which total variation defined the 
variation within studies with estimated variation between studies. 
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2.3 Identification the publication bias 
The existence of publication bias was checked by using a funnel plot or Egger’s linear 
regression test. The funnel plot was a scatter plot of the association measure against a 
inverse of standard error of measure. If the shape of funnel plot about any factor is not 
funnel or cone around the combined MD, the publication bias was doubtable. Egger’s linear 
regression test was used to test the null hypothesis that the funnel plot was not asymmetry. 
Egger’s linear regression is a linear regression of standard normal deviate (defined as 
association measure over SE) against the inverse of SE, and there may be publication bias if 
the estimated intercept is significantly different from 0. A positive intercept indicates that 
more studies are associated with a bigger effect (19).  
2.4 Software used for the meta-analysis 
Version 1.5 of MIX program was used for combining MDs, plotting the funnel plots and 
checking the publication bias. The STATA program was used for meta-regression.  
3. Result  
3.1 Combined mean difference and homogeneity test of studies 
(Fat/Weight/Plasma/Liver) 
The combined MDs between FR and FRC were presented with p-value to test heterogeneity 
of results in Table 1. In the fixed effect model, the MDs were significantly different from 0 
for body fat, final body weight, liver-TC, plasma-TC, plasma-TG and weight gain (<0.05). 
Especially the p-values tested for body fat, final body weight, and weight gain were less 
than 0.01, showing CLA significantly decreased the level of each of them.  
 
 Fixed effect model a) Heterogeneity b) Random effect model a) 
estimate p-value c) p-value estimate p-value c) 
Body fat(%) -1.2504 <0.0001 <0.0001 -1.1239 0.1020 
Epididymal fat (g/100g) -0.0131 0.6988 <0.0001 -0.0470 0.4512 
Fat cell size(μm) -0.6088 0.4707 0.4213 -0.6088 0.4770 
Final body weight(g) -3.5922 0.0004 <0.0001 -3.3114 0.3941 
Food intake(g/d) -0.1639 0.1190 0.1829 -0.2235 0.2634 
Leptine(pg/ml) -6.6161 0.7563 0.0696 33.5415 0.4738 
Liver-TC(mg/g) -0.1859 0.0352 0.0146 -0.5187 0.2483 
Liver-TG(mg/g) -0.2007 0.2689 <0.0001 -0.8575 0.2539 
Plasma-TC(mg/dl) -11.5280 <0.0001 0.0087 -15.0920 0.0009 
Plasma-TG(mg/dl) -3.2202 0.0446 0.0730 -4.0647 0.1287 
Weight gain(g/d) -0.5377 <0.0001 <0.0001 -0.1561 0.5062 
Table 1. Combined MDs and Homogeneity test in fixed effect model and random effect 
model. a)  
The fixed effect model was inadequate in terms of body fat, epididymal fat, final body 
weight, liver-TC, liver-TG, plasma-TC, plasma-TG and weight gain, because of the 
heterogeneity of studies for them (p-value<0.05). The MD about heterogeneity factor was 
regressed against two covariates, amount and period of CLA supplementation, by meta-
regression method in Table 2. Only the MD of the final body weight was significantly 
correlated with the period of CLA supplementation (p-value <0.05), and the coefficient of 
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period was estimated -0.0698. That meant the MD of the final body weight was estimated to 
decrease by 0.0698 per unit increase in the period. 
The random effect model was used to combine MD on heterogeneity factors; body fat, 
epididymal fat, final body weight, liver-TC, liver-TG, plasma-TC, plasma-TG, and weight 
gain. The value of the MD of plasma-TC was significantly negative, but the value of the MD 
of other factors was not negative.  
 
Factor(unit) Intercept Coefficient of amount Coefficient of period 
Body fat(%) -0.1278 -1.9423 0.0038 
Epididymal fat(g/100g) 0.0203 -0.3859 -0.0003 
Final body weight(g) 1.7030 4.5770 -0.0698 b) 
Liver-TC(mg/g) NA  
Liver-TG(mg/g) -2.6548 -13.8573 0.0947 
Plasma-TC(mg/dl) -1.2486 13.5180 0.0032 
Plasma-TG(mg/dl) -2.1294 -10.2354 0.0681 
Weight gain(g/d) -0.0165 -0.0914 0.0004 
a)  If it is found to be hetero in the effect of treatment between studies, then meta-regression can be used 
to analyze associations between treatment effect and covariates in study.  
b)  The estimated coefficient of period was significantly efficient to combined mean difference about final 
body weight between the FR and the FRC(p-value <0.05), thus the MD of final body weight is estimated 
to decrease by 0.0698 per unit increase in the period. 
Table 2. Estimated intercept and coefficient of covariates in meta-regression.  
 
Factor(unit) 
Egger’s linear regression
Intercept a) p-value b) 
Body fat(%) 14.1719 0.3649 
Epididymal fat(g/100g) -1.5864 0.0756 
Fat cell size(μm) 1.5284 0.5107 
Final body weight(g) -0.0471 0.9677 
Food intake(g/d) -0.1382 0.7718 
Leptine(pg/ml) 1.8242 0.2223 
Liver-TC(mg/g) NA  
Liver-TG(mg/g) -2.4299 0.3152 
Plasma-TC(mg/dl) -2.8889 0.0807 
Plasma-TG(mg/dl) -0.7732 0.2357 
Weight gain(g/d) 3.1444 0.5980 
a)  The data were expressed the intercept of Egger’s linear regression about factors.  
b)  The expressed p-values were for testing that the estimated intercept is not significantly different  
with 0.  If the p-value is less than 0.05, the combined MD in Table 1 possibly exist the publication bias, 
and the additional analysis is required. 
Table 3. Estimated intercepts and p-values of Egger’s linear regression test 
3.2 Publication bias 
To check the publication of the funnel plot expressed in Fig. 1. The funnel plots of fat cell size, 
food intake, leptine and plasma-TG were checked in the fixed effect model due to the 
homogeneity. The dots of fat cell size and the dots of leptine were not symmetric by combined 
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MD (solid line), so the publication biases were doubtable. The dots of factors in the random 
effect model were symmetric by solid line, thus the publication bias were ignorable. Since the 
intercepts of Egger’s linear regression by factors in Table 3 were not significant (p-value >0.05), 
the funnel plot on each factor was symmetric and the publication bias was ignorable. 
 
Factor Fixed effect model Random effect model 
Body fat 
 
 
Epididymal 
fat 
 
Fat cell size 
 
Final body 
 Weight 
 
Fig. 1. Funnel plot: In fixed effect model and random effect model 
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Factor Fixed effect model Random effect model 
Food intake  
  
Leptine  
  
Liver-TC  
  
Liver-TG  
  
 
Fig. 1. Funnel plot: In fixed effect model and random effect model (Continuation) 
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Factor Fixed effect model Random effect model 
Plasma-TC  
  
Plasma-TG 
  
Weight gain 
  
Fig. 1. Funnel plot: In fixed effect model and random effect model (Continuation) 
4. Discussion 
4.1 The effects of CLA on the fat depositions 
The factors related with fat deposition were body fat and epididymal fat, and our study 
showed that CLA supplement did not affect the fat deposition. The results of studies on 
body fat and epididymal fat were significantly heterogeneous. In fixed effect model, body 
fat was significantly affected by CLA. Under the heterogeneity of studies on body fat, the 
effect of CLA was not significant in random effect model. We could not check the condition 
of energy expenditure, and that was one of reasons for explaining about heterogeneity.  
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4.2 The effects of CLA on the weights of body 
The results of studies done on the final body weight and weight gain were very 
heterogeneous (p-value < 0.001), and the result of efficiency test of CLA in fixed effect model 
differed from one in random effect model. This situation happened due to extreme one of 
combined results. The extremely negative MD had a small standard error, so the high 
influence of them on combination made significantly negative value in fixed effect model 
but not in random effect model. After omitting the extreme value in analysis, the 
homogeneities results on final body weight and weight gain were accepted (p-value >0.05), 
and the effects of CLA on them were not significant.  
4.3 The effects of CLA on the plasma lipid  
The level of plasma-TC was significantly decreased in FR than in FRC regardless of the 
homogeneity of the factors. Only in fixed effect model, the level of plasma-TG was 
significantly decreased in FR. According to Hwang and Kang, the reduction effect of CLA 
on plasma-TG was significant in the case rats that ware fed with beef tallow for 1 and 4 
weeks and in the case rats that was fed with fish oil only for 4 weeks (20). The anti-obesity 
effect of CLA was assured like Hwang and Kang’s study.   
5. Conclusion 
In this study, the researchers studied about effect of CLA on factors, such as body fat (%), 
epididymal fat (g/100g), fat cell size (μm), final body weight (g), food intake (g/d), leptin 
(pg/ml), liver-TC (mg/g), liver-TG (mg/g), plasma-TC (mg/dl), plasma-TG (mg/dl), and 
weight gain (g/d). The CLA supplement was significantly effective on reduction of body fat 
(%), final body weight (g), liver-TC (mg/g), plasma-TC (mg/dl), plasma-TG (mg/dl), and 
weight gain (g/d) with homogeneity assumption between studies. However, only plasma-
TG was significantly decreased with the random effect model on heterogeneity factors. 
Further study should focus on what the effect of CLA depend on fat source. 
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